These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 805574)

  • 41. Vernolepin: an antiplatelet compound of natural origin.
    Laekeman GM; De Clerck F; Vlietinck AJ; Herman AG
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):108-13. PubMed ID: 3934564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of acetylsalicylic acid and dipyridamole on platelet survival and aggregation in patients with atherosclerosis obliterans.
    Abrahamsen AF; Eika C; Godal HC; Lorentsen E
    Scand J Haematol; 1974; 13(4):241-5. PubMed ID: 4614427
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa.
    Turner NA; Moake JL; Kamat SG; Schafer AI; Kleiman NS; Jordan R; McIntire LV
    Circulation; 1995 Mar; 91(5):1354-62. PubMed ID: 7867173
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of antiplatelet drugs on platelet function tests.
    Sirridge MS; Shannon R; Willoughby TL; Steele P
    Mo Med; 1979 Apr; 76(4):212-7. PubMed ID: 431521
    [No Abstract]   [Full Text] [Related]  

  • 45. Antiplatelet therapy (first of two parts).
    Weiss HJ
    N Engl J Med; 1978 Jun; 298(24):1344-7. PubMed ID: 651993
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of inhibitors of the arachidonate pathway on the release of granule contents from rabbit platelets adherent to collagen.
    Kinlough-Rathbone RL; Cazenave JP; Packham MA; Mustard JF
    Lab Invest; 1980 Jan; 42(1):28-34. PubMed ID: 7351829
    [No Abstract]   [Full Text] [Related]  

  • 47. [Morphofunctional characteristics of the bipolar forms of thrombocytes].
    Buriachkovskaia LI; Markosian RA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):66-72. PubMed ID: 3606835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological investigation of substances affecting platelet function.
    Smith GM
    Acta Cardiol; 1974; Suppl 19():95-102. PubMed ID: 4548299
    [No Abstract]   [Full Text] [Related]  

  • 49. The influence of red blood cells on the effects of aspirin or sulphinpyrazone on platelet adherence to damaged rabbit aorta.
    Davies JA; Essien E; Cazenave JP; Kinlough-Rathbone RL; Gent M; Mustard JF
    Br J Haematol; 1979 Jun; 42(2):283-91. PubMed ID: 465372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proceedings: Inhibition of human platelet aggregation by aspirin in vitro and ex vivo.
    Gordon JL; Macintyre DE
    Br J Pharmacol; 1974 Nov; 52(3):451P. PubMed ID: 4458864
    [No Abstract]   [Full Text] [Related]  

  • 51. Evaluation of the effect of pharmacologic agents on crush-avulsion arterial injuries: a scanning electron microscopy study.
    Savoie FH; Cooley BC; Gould JS
    Microsurgery; 1991; 12(4):292-300. PubMed ID: 1716720
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does the liquid method of electret forming influence the adhesion of blood platelets?
    Lowkis B; Szymanowicz M
    Polim Med; 1995; 25(1-2):3-13. PubMed ID: 7479426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The kinetics of platelet and fibrin deposition on to damaged rabbit carotid arteries in vivo: involvement of platelets in the initial deposition of fibrin.
    Shand RA; Butler KD; Davies JA; Menys VC; Wallis RB
    Thromb Res; 1987 Mar; 45(5):505-15. PubMed ID: 3590089
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prostaglandin D2 inhibits the aggregation of human platelets.
    Smith JB; Silver MJ; Ingerman CM; Kocsis JJ
    Thromb Res; 1974 Sep; 5(3):291-9. PubMed ID: 4439372
    [No Abstract]   [Full Text] [Related]  

  • 55. [Inhibition of platelet adhesiveness and aggregation and protection against cerebral ischemic anoxia by aspirin and 1520 RB. Animal studies].
    Reynier M; Monnier G; Eyraud H; Dubreuil J; Journeau G; Roquet F
    Agressologie; 1977; 18(6):315-24. PubMed ID: 613846
    [No Abstract]   [Full Text] [Related]  

  • 56. Inhibition of platelet adherence to damaged surface of rabbit aorta.
    Cazenave JP; Packham MA; Guccione MA; Mustard JF
    J Lab Clin Med; 1975 Oct; 86(4):551-63. PubMed ID: 1176809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epinephrine reverses the inhibitory influence of aspirin on platelet-vessel wall interactions.
    Rao GH; Escolar G; White JG
    Thromb Res; 1986 Oct; 44(1):65-74. PubMed ID: 3787562
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A scanning electron microscopic investigation of effects of prostacyclin on platelet retention in glass bead columns.
    Ts'ao C; Krajewski D; Ng A
    Scand J Haematol; 1982 Jan; 28(1):23-31. PubMed ID: 7041243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of collagen induced human platelet aggregation.
    Herrmann RG; Lacefield WB; Crowe VG
    Arch Int Pharmacodyn Ther; 1972 Apr; 196(2):316-20. PubMed ID: 5012442
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of class I heparin binding growth factor and fibronectin on platelet adhesion and aggregation.
    Greisler HP; Klosak JJ; Steinam SJ; Lam TM; Burgess WH; Kim DU
    J Vasc Surg; 1990 May; 11(5):665-74. PubMed ID: 1692352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.